Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 11/11/2025Summit and Akeso Report Positive Phase III Results for Ivonescimab at ...
  • 11/11/2025SanegeneBio and Eli Lilly Form RNAi Collaboration in Metabolic Disease...
  • 11/11/2025Innovent and SanegeneBio Present Positive Phase 1 Data for siRNA Thera...
  • 11/11/2025Huahui to Present 48-Week Phase 2b Data of Libevitug at AASLD 2025
  • 11/11/2025MeiraGTx and Eli Lilly Form Strategic Partnership to Advance Gene Ther...
  • 11/11/2025AZ's Evinova and Harbour BioMed Form AI Partnership to Advance Biologi...
  • 11/7/2025Recent Executive Moves
  • 11/7/2025NMPA Pilots Streamlined Review Pathway for Supplemental Applications o...
  • 11/7/2025UniXell Secures CNY 100M in Series A+ Financing to Advance Stem Cell ...
  • 11/7/2025Vigonvita Life Sciences Debuts on HKSE
  • 11/7/2025Lepu to Present Promising Phase II Data of CD20 ADC MRG001 Plus Orelab...
  • 11/7/2025CARsgen Reports Positive Results for Allogeneic CAR-T Therapies CT0596...
  • 11/7/2025Sanofi's Cablivi Wins Approval in China as First Nanobody Therapy for ...
  • 11/7/2025Correctseq Reports World's First Gene-Editing Treatment for Hyperlipid...
  • 11/6/2025Innorna Reportedly Targets $200M Hong Kong IPO to Accelerate Drug Deve...
  • 11/6/2025Clariant Completes Expansion of Pharma Excipients and Specialty Chemic...
  • 11/6/2025AstraZeneca Adds CNY 990M Investment to Qingdao Inhalants Plant
  • 11/6/2025Lilly Expands AI Collaboration with XtalPi, Ends CNS Research Pact wit...
  • 11/6/2025Ivacta Raises CNY 100M+ in Angel Round Led by Qiming Venture Partners
  • 11/6/2025China Grants Conditional Approval for ACEA's COVID-19 Antiviral Olgotr...
  • 11/6/2025Novartis Wins China Approval for Two Pluvicto Indications
  • 11/6/2025Dermavon Files for Hong Kong IPO to Advance Innovative Skin Health Por...
  • 11/6/2025Suzhou Ribo Life Science Files for Hong Kong IPO as siRNA Pipeline Adv...
  • 11/6/2025BrightGene Advances Metabolic Drug Pipeline as It Files for Hong Kong ...
  • 11/5/2025AbbVie's CD20×CD3 Bispecific Epcoritamab Fails to Win China Approval
  • 11/5/2025Lumosa's Stroke Drug Achieves Phase IIb Success in China
  • 11/5/2025China Expands Drug Access Through 11th National Bulk-Buy and New 2025 ...
  • 11/5/2025Senior CSPC Executive Fined CNY 5M for Insider Trading
  • 11/5/2025Bayer Deepens Investment in China's Booming Biopharma Sector
  • 11/5/2025China to Expand Use of Artificial Intelligence Across Health Sector by...
  • Page:16/60 Total number of articles:1794: [First][<<] [14] [15] [16] [17] [18] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group